Best Investing Advice
  • Politics
  • Economy
  • Forex
  • Stock
  • Editor’s Pick
  • Politics
  • Economy
  • Forex
  • Stock
  • Editor’s Pick
No Result
View All Result
Best Investing Advice
No Result
View All Result

Bullish Breadth Improvement Suggests Further Upside For Stocks

admin by admin
May 14, 2025
in Stock
0
Bullish Breadth Improvement Suggests Further Upside For Stocks

We’ve been cautious about the uptrend phase off the April low for a number of reasons, including the lack of breadth support.  While short-term measures of breadth had turned more positive, the long-term breadth conditions had remained firmly in the bearish realm.  With the renewed strength in risk assets over the last week, our long-term breadth measures now indicate a healthy uptrend phase.  

Today we’ll dive a little deeper into one of those breadth indicators, talk about why we track moving average breadth, and show how this recent bullish signal could be a sign of stronger price action to come.

Here we’re showing the S&P 500 on a closing basis along with its 50-day and 200-day moving averages.  Below that, we’re tracking the percent of S&P 500 stocks above their 200-day moving average, followed by the percent of stocks above their 50-day moving average.

Starting at the bottom, we can see that less than 10% of S&P 500 members were above their 50-day moving average at the April 2025 low.  The last time we had reached below the 10% level was back in October 2023, just before a significant market bottom.

While the surge in this short-term breadth indicator over the last month has suggested a tactical rally, the panel above shows how there were still less than 50% of S&P 500 members above their 200-day moving average.  So most stocks had regained the short-term moving average, but were still languishing below the long-term moving average.

As risk assets have surged higher this week, it’s meant enough upside momentum that now most S&P 500 members are back above their 200-day moving average.  Now let’s look at a longer-term time frame and consider previous instances where this long-term moving average breadth indicator has gone from below 25% to above 50%.

We’ve identified eight occurrences of this pattern since the 2009 market low.  In all eight occurrences, the S&P 500 has experienced positive returns in the next 12 months.  And with the exception of the signal in October 2015, we haven’t seen any retest of the previous swing low.

Let’s dig into that 2015 example a little further, and you’ll see what differentiated that particular signal from all the others.

In all the other occurrences, the S&P 500 broke above its 200-day moving average and held that crucial level of support.  In Q4 2015, however, the S&P 500 failed to hold the 200-day moving average, and the breadth indicators soon rotated back to a bearish phase.

It took another attempt in March 2016 before the chart finally resolved to the upside, with the S&P 500 leaving the 200-day moving average behind as it continued to push higher.  Breadth indicators continued to improve as investors began to believe in the bull market of 2016.

I was taught that “nothing good happens below the 200-day moving average,” which also implies that good things can definitely happen above this long-term trend barometer.  At this point, given the bullish breadth rotation that we’ve observed off the April low, I would say that as long as the S&P 500 remains above its 200-day moving average, then we stand a serious chance of further upside from here.

If, however, the SPX fails to hold this crucial line of support, and the index falls back below the 5750 level, then we may be looking at more of a 2015-style retracement as fears rise and stocks drop.

RR#6,

Dave

PS- Ready to upgrade your investment process?  Check out my free behavioral investing course!

David Keller, CMT

President and Chief Strategist

Sierra Alpha Research LLC

marketmisbehavior.com

https://www.youtube.com/c/MarketMisbehavior

Disclaimer: This blog is for educational purposes only and should not be construed as financial advice.  The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional.  

The author does not have a position in mentioned securities at the time of publication.    Any opinions expressed herein are solely those of the author and do not in any way represent the views or opinions of any other person or entity.

Previous Post

Tariff Tensions Ease, Nasdaq Soars — But is SMH the Emerging Leader?

Next Post

Gold Price Drops Over US$100 as US and China Agree to Tariff Pause

Next Post
Gold Price Drops Over US$100 as US and China Agree to Tariff Pause

Gold Price Drops Over US$100 as US and China Agree to Tariff Pause

Subscribe to InvestiStratix.com

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular News

    Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone

    Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone

    May 15, 2025
    Eric Nuttall: Oil vs. Natural Gas Stocks, Plus 2025 Prices, Supply and Demand

    Eric Nuttall: Oil vs. Natural Gas Stocks, Plus 2025 Prices, Supply and Demand

    May 15, 2025
    EL2780 Award – New Targets from Airborne MT

    EL2780 Award – New Targets from Airborne MT

    May 15, 2025
    SAGA Metals Appoints Vernon Shein, Former Exploration Manager at B2Gold, to its Board of Advisors

    SAGA Metals Appoints Vernon Shein, Former Exploration Manager at B2Gold, to its Board of Advisors

    May 15, 2025
    AMERICAN SALARS ADDS LITHIUM BRINE EXPERT DR. MARK KING AS A TECHNCIAL ADVISOR AND QUALIFIED PERSON

    AMERICAN SALARS ADDS LITHIUM BRINE EXPERT DR. MARK KING AS A TECHNCIAL ADVISOR AND QUALIFIED PERSON

    May 15, 2025

    Trending News

    Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone

    Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone

    May 15, 2025
    Eric Nuttall: Oil vs. Natural Gas Stocks, Plus 2025 Prices, Supply and Demand

    Eric Nuttall: Oil vs. Natural Gas Stocks, Plus 2025 Prices, Supply and Demand

    May 15, 2025

    About Us

    • About us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 bestinvestingadvice.com | All Rights Reserved

    No Result
    View All Result
    • Politics
    • Economy
    • Forex
    • Stock
    • Editor’s Pick

    Copyright © 2025 bestinvestingadvice.com | All Rights Reserved